The new boosters target the omicron BA.4 and BA.5 strains of the COVID-19 virus which are currently the most prevalent in the United States. Two versions of bivalent boosters are available: The Pfizer-BioNTech for people ages 12 years and older and Moderna for people ages 18 years and older.
